Dopaminergic therapy in children with restless legs/periodic limb movements in sleep and ADHD

Pediatric Neurology

Volumn 22, Issue 3, 2000, Pages 182-186

  Walters, Arthur S ^a,c   Mandelbaum, David E ^a   Lewin, Daniel S ^a,d   Kugler, Steven ^a   England, Sandra J ^b   Miller, Michael ^a  

^a UNIVERSITY OF MEDICINE AND DENTISTRY OF NEW JERSEY   (United States)

^b ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

^c Vet Aff New Jersey Hlth Care S   (United States)

^d UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBIDOPA PLUS LEVODOPA; DOPAMINE RECEPTOR STIMULATING AGENT; LEVODOPA; METHYLPHENIDATE; PEMOLINE MAGNESIUM; PERGOLIDE; PERGOLIDE MESILATE;

ADOLESCENT; ARTICLE; ATTENTION DEFICIT DISORDER; CLINICAL ARTICLE; FEMALE; HUMAN; LIMB MOVEMENT; MALE; PRIORITY JOURNAL; RESTLESS LEGS SYNDROME; SCHOOL CHILD;

ADOLESCENT; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; CHILD; DOPAMINE; DOPAMINE AGONISTS; HUMANS; MALE; NOCTURNAL MYOCLONUS SYNDROME; PERGOLIDE; POLYSOMNOGRAPHY; REMISSION INDUCTION; RESTLESS LEGS SYNDROME; TREATMENT OUTCOME;

EID: 0034061657     PISSN: 08878994     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0887-8994(99)00152-6     Document Type: Article

References (41)

1. Walters AS (Group Organizer and Correspondent) for the International Restless Legs Syndrome Study Group. Toward a better definition of the restless legs syndrome. Mov Disord 1995;10:634-42.
2. Diagnostic Classification Steering Committee (Thorpy MJ, chair). Periodic limb movement disorder. In: International classification of sleep disorders: diagnostic and coding manual. Rochester, Minnesota: American Sleep Disorders Association, 1990:65-8.
3. Montplaisir J., Boucher S., Poirier G., Lavigne G., Lapierre O., Lesperance P. Clinical polysomnographic and genetic characteristics of restless legs syndrome a study of 133 patients diagnosed with new standard criteria . Mov Disord. 12:1997;61-65.
4. Walters A.S., Picchietti D.L., Ehrenberg B.L., Wagner M.L. Restless legs syndrome in childhood and adolescence. Pediatr Neurol. 11:1994;241-245.
5. Picchietti D.L., Walters A.S. Moderate to severe periodic limb movement disorder in childhood and adolescence. Sleep. 22:1999;297-300.
6. Picchietti D.L., England S.J., Walters A.S., Willis K., Verrico T. Periodic limb movement disorder and restless legs syndrome in children with attention-deficit-hyperactivity disorder. J Child Neurol. 13:1998;588-594.
7. Picchietti D.L., Underwood D.J., Farris W.A., et al. Further studies on periodic limb movement disorder and restless legs syndrome in attention-deficit-hyperactivity disorder children. Mov Disord. 14:1999;1000-1007.
8. Weissbluth M., Davis A.T., Poncher J., Reiff J. Signs of airway obstruction during sleep and behavioral, developmental and academic problems. J Dev Behav Pediatr. 4:1983;119-121.
9. Guilleminault C., Winkle R., Korobkin R., Simmons B. Children and nocturnal snoring Evaluation of the effects of sleep related respiratory resistive load and daytime functioning . Eur J Pediatr. 139:1982;165-171.
10. Weinberg W.A., Graham J.E. Attention-deficit-hyperactivity-disorder The differential diagnosis . J Child Neurol. 6:(Suppl):1991;S23-S36.
11. Clark M., Duane D.D. HLA-typing in three families with two generations of concurrent hypersomnia and attention-deficit-hyperactivity-disorder. Neurology. 45:(Suppl 4):1995;A433.
12. Weinberg W.A., Brumback R.A. The myth of attention-deficit-hyperactivity disorder Symptoms resulting from multiple causes . J Child Neurol. 7:1992;431-445.
13. Gozal D. Sleep-disordered breathing and school performance in children. Pediatrics. 1:1998;616-620.
14. Chervin R.D., Dillon J.E., Bassetti C., Ganoczy D.A., Pituch K.J. Symptoms of sleep disorders, inattention and hyperactivity in children. Sleep. 20:1997;1185-1192.
15. Weinberg W.A., Harper C.R. Attention-deficit-hyperactivity disorder A disease or a symptom complex? J Pediatr. 130:1997;665-669.
16. Shaywitz B.A., Shaywitz S.E. Co-morbidity A critical issue in attention-deficit disorder . J Child Neurol. 6:(Suppl):1991;S13-S20.
17. Brodeur C., Montplaisir J., Godbout R., Marinier R. Treatment of restless legs syndrome and periodic movements during sleep with L-dopa A double-blind, controlled study . Neurology. 38:1988;1845-1848.
18. Trenkwalder C., Stiasny K., Pollmacher T., et al. L-dopa therapy of uremic and idiopathic restless legs syndrome A double blind crossover trial . Sleep. 18:1995;681-688.
19. Walters A.S., Hening W.A., Kavey N., Chokroverty S., Gidro-Frank S. A double blind randomized crossover trial of bromocriptine and placebo in restless legs syndrome. Ann Neurol. 24:1988;455-458.
20. Earley C.J., Yaffee J.B., Allen R.P. Randomized, double-blind, placebo-controlled trial of pergolide in restless legs syndrome. Neurology. 51:1998;1599-1602.
21. Silber M.H., Shepard J.W. Jr, Wishey J.A. Pergolide in the management of restless legs syndrome An extended study . Sleep. 20:1997;878-882.
22. Lin S.-C., Kaplan J., Burger C.D., Fredrickson P.A. Effect of pramipexole in treatment of resistant restless legs syndrome. Mayo Clinic Proc. 73:1998;497-500.
23. Becker P.M., Ondo W., Sharon D. Encouraging initial response of restless legs syndrome to pramipexole. Neurology. 51:1998;1221-1223.
24. Ondo W. Ropinirole for restless legs syndrome. Mov Disord. 14:1999;138-140.
25. Committee on Nomenclature and Statistics, American Psychiatric Association. Attention-deficit/hyperactivity disorder. In: Diagnostic and statistical manual of nervous disorders, 4th ed. Washington, DC: American Psychiatric Association, 1994:78-85.
26. Rechtschaffen A., Kales A. A manual of standardized terminology, techniques and scoring system for sleep stages of human subjects. 1968;UCLA Brain Information Service/Brain Research Institute, Los Angeles.
27. EEG Arousals Scoring rules and examples . Sleep. 15:1992;173-184.
28. Goyette C.H., Connors C.K., Ulrich R.F. Normative data on revised Connors parent and teacher rating scales. J Abnorm Child Psych. 6:1978;221-236.
29. Achenbach T.M. Manual for the Child Behavior Checklist 2-3, 1992 Profile. 1992;1-210 Department of Psychiatry, University of Vermont, Burlington, Vermont.
30. Greenberg L.M., Waldman I.D. Developmental normative data on the Test of Variable Attention (T.O.V.A.). J Child Psychol Psychiatry. 34:1993;1019-1030.
31. Mealer CZ. The validity of the WRAML and WISC-III in differentiating ADHD boys, clinic-referred boys, and non-clinic referred boys. Dissertation Abstracts International: Section B: Sciences and Engineering, 1995;55(10-B):4609.
32. Amara S., Kuhar M. Neurotransmitter transporters Recent progress . Ann Rev Neurosci. 16:1993;73-93.
33. LaHoste G.J., Swanson J.M., Wigal S.B., et al. Dopamine D4 receptor gene polymorphism is associated with attention deficit hyperactivity disorder. Mol Psychiatry. 1:1996;121-124.
34. Waldman I.D., Rowe D.C., Abramowitz A., et al. Association and linkage of the dopamine transporter gene and attention-deficit-hyperactivity disorder in children Heterogeneity owing to diagnostic subtype and severity . Am J Hum Genet. 63:1998;1767-1776.
35. Reimherr F.W., Wood D.R., Wender P.H. An open clinical trial of L-dopa and carbidopa in adults with minimal brain dysfunction. Am J Psychiatry. 137:1980;73-75.
36. Jackson R., Pelton E. L-dopa treatment of children with hyperactive behavior. Neurology. 28:1978;331.
37. Gross M.D. Improvement with L-dopa in a hyperkinetic child. Dis Nerv Syst. 38:1977;556-557.
38. Langer D.H., Rapoport J.L., Brown G.L., Ebert M.H., Bunney W.E. Behavioral effects of carbidopa/levodopa in hyperactive boys. J Am Acad Child Psychiatry. 21:1982;10-18.
39. Wood D., Reimherr F., Wender P.H. Effects of levodopa on attention-deficit disorder, residual type. Psychiatry Res. 6:1982;13-20.
40. Wood D.R., Reimherr F.W., Wender P.H. The use of L-Deprenyl in the treatment of attention deficit disorder, residual type. Psychopharmacol Bull. 19:1983;627-629.
41. Muller U., Von Cramon D.Y., Pollmann S. D1- versus D2-receptor modulation of visuospatial working memory in humans. J Neurosci. 18:1998;2720-2728.